ORPHENADRINE IN THE TREATMENT OF DEPRESSION
Abstract
In this preliminary study, 14 psychiatric patients with depressive features were treated with orphenadrine to determine if the euphoric action, previously reported as a side-reaction in nonpsychiatric patients, occurs and is beneficial in depression. Two of the patients were rated as recovered; 9 showed beneficial effects including improved behavior, more optimism concerning the future, decreased anxiety and agitation. Further dies with adequate controls and a double blind technique are warranted to determine if orphenadrine can prove useful in the treatment of depressed psychiatric patients.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
